For the month ended 31 October 2026, China Health Group Limited reported stable share capital with no movements in either authorised or issued shares, according to its monthly return filed on 4 November 2026 with Hong Kong Exchanges and Clearing Limited.

Authorised Capital • Ordinary shares remained at 100.00 billion with a par value of HKD 0.10, representing authorised share capital of HKD 10.00 billion. • Redeemable Convertible Cumulative Preference Shares held steady at 15,000 shares with a par value of USD 0.01 (equivalent to HKD 1,164 using an illustrative USD/HKD rate of 7.76).

Issued Shares and Public Float • Issued ordinary shares were unchanged at 1.39 billion; no treasury shares were held or cancelled. • The company confirmed compliance with the minimum 25% public-float requirement as at month-end.

Share Option Scheme • Outstanding options under the 2012 Share Option Scheme totalled 20.84 million, unchanged during the month. • No new shares were issued and no treasury shares were transferred pursuant to option exercises, resulting in zero funds raised in October.

Other Securities • The issuer reported no warrants, convertibles, or other agreements that could lead to additional share issuance during the period.

Governance Confirmation • The filing affirmed that all corporate actions during the month were duly authorised and complied with listing rules and applicable regulations.

Overall, China Health recorded a static capital structure in October 2026, maintaining its authorised and issued share counts, upholding public-float requirements, and leaving its outstanding share options unchanged.